Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 27 October 2022, 18:04 HKT/SGT
Share:
    

Source: Eminence Business Media
Watch the Biggest T10 Indian Pharma Championship on VOOT live

MUMBAI, INDIA, Oct 27, 2022 - (ACN Newswire) - Keeping the spirit of cricket in mind, Eminence Business Media is proud to announce T10 Indian Pharma Champions Trophy 2022 scheduled for December 1-7, 2022, in Mumbai. Managing Director of Eminence Business Media, Ms. Guneet Kaur Hayer, believes that cricket is not just a sport for many; it is an emotion and as a company they want people to take a short rejuvenating break from their tiring work, and to do something that works for their physical health, mental health, and fitness at par. She also said it is every company's responsibility to keep their employees healthy, fit, engaged, appreciated and happy with their jobs.


For the first time ever, a cricket league of such a high stature has been announce exclusively for the Pharmaceutical Industry that would make an enduring impact on people's lives. It provides great entertainment, teaches important skills; physical, mental, and social.

What's in It for the Pharma Teams?
1. Winning prize money for up to INR 25 Lakhs.
2. Live streaming gives that celebrity vibe to show your talent on the screen to 20 million viewers.
3. Four-wheeler, two wheelers and several other remunerative awards for Man of the Series, Man of the Matches, Purple Hat, Orange Hat Winners and more.
4. Win gadgets like Laptops, mobiles and more.
5. Best of all is the joy of playing cricket and winning the championship.
6. Support NGO by participating, or partnering, where in part percentage will go in donation to them.

What's in It for the Sponsors?
1. Exclusive Brand Positioning & Visibility.
2. Exclusive marketing
3. Live streaming on VOOT across the nation.
4. On air campaigns in multiple cities.
5. Network and enhance your market reach.
6. Pre- scheduled meetings.
7. Support NGO by participating, or partnering, where in part percentage will go in donation to them.


Topic: Press release summary
Source: Eminence Business Media


http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
Doubleview Provides Cobalt Resource Summary for the Hat Polymetallic Deposit in Advance of Updated MRE and PEA  
Dec 2, 2025 21:59 HKT/SGT
OpenAI Joins the Global Anti-Scam Alliance as Foundation Member to Strengthen Global Response Against AI-Enabled Scams  
Dec 2, 2025 21:00 HKT/SGT
Digital Realty and BW Digital Partner to Support Expansion of Cross-Border Connectivity Between Singapore and Batam  
Dec 2, 2025 15:49 HKT/SGT
GEN Announces New Positive Phase 1 Trial Data of the Investigational Drug SUL-238 for Alzheimer's and Other Neurodegenerative Diseases  
Dec 2, 2025 13:00 HKT/SGT
AdipoLABs Opens New Regional Office, Signs Two MoUs With University of Cyberjaya to Advance Healthcare Innovation  
Dec 2, 2025 12:22 HKT/SGT
Fujitsu achieves high-precision, long-duration molecular dynamics simulation for all-solid-state battery interphases with over 100,000 atoms  
Monday, December 1, 2025 10:04:00 PM
Fujitsu develops multi-AI agent collaboration technology to optimize supply chains, launches joint trials  
Monday, December 1, 2025 9:43:00 PM
GMG Launches Pre-Order Sales for First to Market Multi Language THERMAL-XR(R) Kit with Electric Spray Gun  
Dec 1, 2025 21:29 HKT/SGT
Fujitsu launches 'Fujitsu Accelerator Program for SPORTS' to create new value through Sports x Technology  
Monday, December 1, 2025 9:14:00 PM
HashKey Passes HKEX Hearing: From Asia's Compliance Pioneer to a Global Institutional Gateway for Digital Assets  
Dec 1, 2025 18:39 HKT/SGT
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: